Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients
Clinical trial NCT06098560 · RECRUITING
Trial details
- NCT number
- NCT06098560
- Sponsor
- Geneplus-Beijing Co. Ltd.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-30
- Primary completion
- 2026-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.